Dealing in securities by a director Super Group Limited (Incorporated in the Republic of South Africa) (Registration number: 1943/016107/06) Share code: SPG ISIN: ZAE000161832 (“Super Group”) DEALING IN SECURITIES BY A DIRECTOR 1. In compliance with paragraphs 3.63 to 3.66 of the Listings Requirements, shareholders are advised that a director of Super Group has, in terms of the Share Appreciation Right Scheme 2005 (“the Scheme”), been issued shares in terms of previously accepted grants that have vested. Shareholder approval of the Scheme was obtained at the 2005 Annual General Meeting. All rights have conditions attached and are subject to the rules of the Scheme. The Remuneration Committee approved the grants and the required clearance in terms of paragraph 3.66 of the Listings Requirements was obtained. The Scheme supports the principle of aligning management and shareholder interests. Performance conditions governing the vesting of these rights are intended to be stretching but achievable. The performance conditions are related to headline earnings per share increasing by 2% per annum above the Consumer Price Inflation Index over the three year performance period ended 30 June 2013. The grants are conditional upon the participant remaining employed during the performance period. The grants that have vested have been awarded in terms of performance conditions for the Financial Year ended 30 June 2013 and the shares have been issued to the following director. Name of director Number of Share Number of Shares Nature of interest Appreciation Issued (1) Rights (“SARS”) C Brown 300 000 234 526 Direct, Beneficial Date of transfer 18 March 2014 Nature of transaction Issue of shares Class of securities Ordinary shares Strike price of SARS R6.10 Strike date 18 March 2014 Exercise Price of SARS R27.9500 Vesting date Following approval by the Remuneration Committee based on the audited results for the year ended 30 June 2013 Name of director Number of Share Number of Shares Nature of interest Appreciation Issued (1) Rights (“SARS”) C Brown 200 000 147 764 Direct, Beneficial Date of transfer 18 March 2014 Nature of transaction Issue of shares Class of securities Ordinary shares Strike price of SARS R7.30 Strike date 18 March 2014 Exercise Price of SARS R27.9500 Vesting date Following approval by the Remuneration Committee based on the audited results for the year ended 30 June 2013 (1)The number of shares issued is calculated by the total gain on the SARS, which is the difference between the strike price and the exercise price multiplied by the number of SARS. The gain is then divided by the exercise price to determine the number of shares issued. 2. In compliance with paragraphs 3.63 to 3.66 of the Listings Requirements, Super Group advises that it has been informed of the following dealings in its shares: Director Colin Brown Company Super Group Date of transaction 19 March 2014 Nature of transaction Sale of shares on market Nature of interest Direct, beneficial Class of securities Ordinary shares Clearance to deal Yes Number of shares sold 311 765 Highest Price R28.4700 Lowest Price R28.2000 Volume Average Weighted R28.2545 Price Total value of transaction R8 808 764.71 Director Colin Brown Company Super Group Date of transaction 20 March 2014 Nature of transaction Sale of shares on market Nature of interest Direct, beneficial Class of securities Ordinary shares Clearance to deal Yes Number of shares sold 70 525 Highest Price R28.0600 Lowest Price R27.9500 Volume Average Weighted R27.9734 Price Total value of transaction R1 972 822.60 The required clearance per paragraph 3.66 of the Listings Requirements was obtained. The transactions are not a reflection of his views on the Group and simply represent diversification of investments. Sandton 20 March 2014 Sponsor: Deutsche Securities (SA) Proprietary Limited Date: 20/03/2014 03:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.